Drug Shortage Report for PRO-RABEPRAZOLE
Report ID | 93043 |
Drug Identification Number | 02315181 |
Brand name | PRO-RABEPRAZOLE |
Common or Proper name | PRO-RABEPRAZOLE |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-12-31 |
Actual start date | 2020-01-07 |
Estimated end date | Unknown |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-07-11 | French | Compare |
v7 | 2023-07-11 | English | Compare |
v6 | 2020-01-08 | English | Compare |
v5 | 2020-01-07 | French | Compare |
v4 | 2020-01-07 | English | Compare |
v3 | 2020-01-01 | English | Compare |
v2 | 2019-09-05 | French | Compare |
v1 | 2019-09-05 | English | Compare |
Showing 1 to 8 of 8